Ahmedabad-based pharma major Torrent Pharmaceuticals posted a 175 per cent jump in net profit to Rs 357 crore for the fourth quarter of the fiscal 2015-16, while its revenues jumped 30 per cent on a year on year basis to Rs 1,499 crore.
The Gujarat High Court has sanctioned the scheme of amalgamation of Zyg Pharma with the company with effect from October 1, 2015. As for the India business, domestic formulations recorded revenues of Rs 447 crore for the quarter, up 13 per cent. The Brazil business, however, declined by 16 per cent to Rs 119 crore.
The US revenues which stood at Rs 514 crore, were up 128 per cent.
For the full year, the revenues were up 43 per cent to Rs 6,676 crore, while the PAT was up 129 per cent to Rs 2,930 crore.